MicroSintesis

About:

MicroSintesis is a life science company

Website: http://microsintesis.com/

Top Investors: Northern Private Capital (NPC)

Description:

MicroSintesis is a new life sciences company focused on creating novel anti-infectives. MicroSintesis has developed a unique technology that uses natural bioactive molecules produced by probiotics to reduce significantly the expression of the virulence genes of multiple pathogenic bacteria. The result is a new way to reduce antibiotic use and create a first line of defense in the fight against antibiotic resistance bacteria.